Due to a high load of modelling projects, the rate of submission via the website has been reduced.
For a much higher submission rate, please use the Modelling API.

A0A6V7AN48 (A0A6V7AN48_SARS2) Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2)

Nucleocapsid phosphoprotein UniProtKBInterProInteractive Modelling

419 aa; Sequence (Fasta) ; 4 identical sequences: Severe acute respiratory syndrome coronavirus 2: P0DTC9, A0A6B9VLF5, A0A6C0T6Z7, A0A6V7AMQ7

Available Structures

69 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Crystal Structure of Human Fab S24-202 in the complex with the N-terminal Domain of Nucleocapsid pr… Heteromer
P0DTC9;
47-173
EDO; 12×IOD;PO4;
Assess
Structure of the SARS-CoV-2 N protein RNA-binding domain bound to single-domain antibody C2 Heteromer
P0DTC9;
49-174
SO4;
Assess
Crystal Structure of Human Fab S24-1063 in the Complex with the N-teminal Domain of Nucleocapsid Pr… Heteromer
P0DTC9;
47-172
EDO;
Assess
Structure of the SARS-CoV-2 N protein RNA-binding domain bound to single-domain antibody B6 Heteromer
P0DTC9;
49-174
Assess
Crystal Structure of Human Fab S24-188 in the complex with the N-teminal Domain of Nucleocapsid pro… Heteromer
P0DTC9;
47-172
Assess
Complex structure of a human monoclonal antibody with SARS-CoV-2 nucleocapsid protein NTD Heteromer
P0DTC9;
48-172
ZN;
Assess
Crystal Structure of Human Fab S24-1379 in the Complex with the N-teminal Domain of Nucleocapsid Pr… Heteromer
P0DTC9;
49-173
Assess
Crystal structure of the SARS-CoV-2 nucleocapsid protein N-terminal domain in complex with Ubl1 Heteromer
P0DTC9; P0DTD1;
49-173
Assess
Crystal Structure of Human Fab S24-1564 in the complex with the N-terminal Domain of Nucleocapsid p… Heteromer
P0DTC9;
49-171
EDO;CL;
Assess
Two monobodies recognizing the conserved epitopes of SARS-CoV-2 N antigen applicable to the broad C… Heteromer
P0DTC9;
251-364
SO4;
Assess
Structure of the SARS-CoV-2 N protein C-terminal domain bound to single-domain antibody E2 Heteromer
P0DTC9;
269-364
Assess
Structure of SARS-CoV-2 nucleoprotein in dynamic complex with its viral partner nsp3a Heteromer
P0DTC9; P0DTD1;
191-263
Assess
Crystal Structure of the G3BP1 NTF2-like domain bound to the IDR1 of SARS-CoV-2 nucleocapsid protei… Heteromer
P0DTC9; Q13283;
12-25
Assess
Crystal Structure of the G3BP1 NTF2-like domain bound to the IDR1 of SARS-CoV-2 nucleocapsid protein Heteromer
P0DTC9; Q13283;
12-22
Assess
SARS-CoV-2 Nucleocapsid phosphopeptide 201-210 bound to human 14-3-3 sigma Heteromer
P0DTC9; P31947;
201-210
CL;
Assess
Crystal Structure of HLA-A*0201in complex with SARS-CoV-2 N222-230 Heteromer
P0DTC9; P61769; Q861F7;
222-230
CD;CA;EDO;
Assess
Crystal Structure of HLA-A*0201 in complex with SARS-CoV-2 N316-324 Heteromer
P0DTC9; P61769; Q861F7;
316-324
ACT;CD;NA;
Assess
A COVID-19 T-cell response detection method based on a newly identified human CD8+ T cell epitope f… Heteromer
A0A6M6CC39; P0DTC9; P61769;
361-369
Assess
Crystal Structure of HLA-A*0201in complex with SARS-CoV-2 N159-167 Heteromer
P0DTC9; P61769; Q861F7;
159-167
Assess
Crystal Structure of HLA-A*0201 in complex with SARS-CoV-2 N138-146 Heteromer
P0DTC9; P61769; Q861F7;
138-146
CD;ACT;
Assess
Crystal Structure of HLA-A*0201in complex with SARS-CoV-2 N351-359 Heteromer
P0DTC9; P61769; Q861F7;
351-359
3NI;CL;CD;
Assess
Crystal Structure of the G3BP1 NTF2-like domain bound to the IDR1 of SARS-CoV-2 nucleocapsid protei… Heteromer
P0DTC9; Q13283;
12-20
Assess
HLA-B*07:02 in complex with SARS-CoV-2 nucleocapsid peptide N105-113 Heteromer
P01889; P0DTC9; P61769;
105-113
CL;
Assess
SARS-CoV-2 specific T cell receptor Heteromer
P0DTC9; P61769; U5YKE0;
222-230
Assess
SARS-CoV-2 Nucleocapsid phosphopeptide 193-200 bound to human 14-3-3 sigma Heteromer
P0DTC9; P31947;
193-200
PEG;GOL;BR;TRS;
Assess
14-3-3 in complex with SARS-COV2 N phospho-peptide Heteromer
P0DTC9; P63104;
194-200
ACT;GOL;BEZ;
Assess
Crystal Structure of HLA-A*0201 in complex with SARS-CoV-2 N226-234 Heteromer
P0DTC9; P61769; Q861F7;
226-228
CD;NA;ACT;
Assess
GQTVTK segment from the Nucleoprotein of SARS-CoV-2, residues 243-248homo-18-mer243-248
Assess
AALALL segment from the Nucleoprotein of SARS-CoV-2, residues 217-222, crystal form 2homo-18-mer217-222
36×PG4;
Assess
Crystal structure of N-terminal domain of Nucleocapsid protein of SARS-CoV-2homo-16-mer46-175
GOL;
Assess
GSQASS segment from the Nucleoprotein of SARS-CoV-2, residues 179-184homo-16-mer179-184
Assess
AALALL SEGMENT FROM THE NUCLEOPROTEIN OF SARS-COV-2, RESIDUES 217-222, CRYSTAL FORM 1homo-12-mer217-222
18×TFA;
Assess
Crystal structure of SARS-CoV2 N-NTD complexed with 5-Benzyloxygraminehomo-4-mer46-174
DJU;
Assess
Crystal structure of SARS-CoV2 N-NTD complexed with 5-Benzyloxygramine derivative (P3-8)homo-4-mer46-174
U2H;
Assess
Crystal structure of RNA-binding domain of nucleocapsid phosphoprotein from SARS CoV-2, monoclinic …homo-4-mer48-173
ZN;MES;
Assess
Crystal structure of RNA binding domain of nucleocapsid phosphoprotein from SARS coronavirus 2homo-4-mer49-173
MES;CL;ZN;GOL;
Assess
Crystal structure of SARS-CoV-2 N-NTDhomo-4-mer49-173
ZN;MES;
Assess
SARS-CoV-2 Nucleocapsid dimer structure determined from COVID-19 patientshomo-2-mer1-419
Assess
Crystal Structure of C-terminal Dimerization Domain of Nucleocapsid Phosphoprotein from SARS-CoV-2,…homo-2-mer247-364
Assess
Crystal Structure of SARS-CoV-2 N-CTD in complex with GTP (I)homo-2-mer247-364
Assess
1.45 Angstrom Resolution Crystal Structure of C-terminal Dimerization Domain of Nucleocapsid Phosph…homo-2-mer249-364
Assess
Crystal structure of SARS-CoV-2 nucleocapsid protein C-terminal RNA binding domainhomo-2-mer250-364
PEG;
Assess
Structure of SARS-CoV-2 Nucleocapsid dimerization domain, P21 formhomo-2-mer251-364
SO4;
Assess
Crystal structure of the C-terminal domain of SARS-CoV-2 nucleocapsid proteinhomo-2-mer252-364
ACT;PEG;
Assess
Crystal Structure of SARS-CoV-2 N-CTD in complex with GTP (II)homo-2-mer253-364
GTP;GOL;
Assess
Structure of SARS-CoV-2 Nucleocapsid dimerization domain, P1 formhomo-2-mer254-364
Assess
Crystal structure of SARS-CoV-2 N-CTDhomo-2-mer254-364
Assess
1.3 Angstrom Resolution Crystal Structure of SARS-CoV-2 Nucleocapsid dimerization domain, pH 8.5homo-2-mer255-364
Assess
Crystal structure of 2019-nCoV nucleocapsid C-terminal domain (CTD) proteinhomo-2-mer255-364
Assess
Crystal structure of SARS-CoV-2 nucleocapsid protein C-terminal domain complexed with Chicoric acidhomo-2-mer256-364
GKP;PEG;GOL;NA;
Assess
Crystal structure of SARS-CoV-2 nucleocapsid protein C-terminal domainhomo-2-mer256-364
GOL;
Assess
Crystal structure of SARS-CoV-2 N-CTD in complex with GMPhomo-2-mer256-364
SCN;5GP;K;CL;
Assess
1.6 Angstrom Resolution Crystal Structure of SARS-CoV-2 Nucleocapsid dimerization domain, pH 5.0homo-2-mer257-364
Assess
2.05 Angstrom Resolution Crystal Structure of C-terminal Dimerization Domain of Nucleocapsid Phosph…homo-2-mer257-364
CL;
Assess
Crystal structure of SARS-CoV-2 nucleocapsid protein C-terminal RNA binding domain at 2.0A resoluti…homo-2-mer257-362
PO4;CL;
Assess
SARS-CoV-2 nucleocapsid protein C-terminal domain (dodecamer)homo-2-mer257-362
Assess
Crystal structure of SARS-CoV-2 N-CTDhomo-2-mer269-367
PO4;
Assess
Nucleocapsid monomer structure from SARS-CoV-2monomer1-419
Assess
The N-terminal RNA-binding domain of the SARS-CoV-2 nucleocapsid phosphoproteinmonomer44-180
Assess
The SARS-CoV-2 nucleocapsid phosphoprotein N-terminal domain in complex with 7mer dsRNAmonomer44-180
Assess
The SARS-CoV-2 nucleocapsid phosphoprotein N-terminal domain in complex with 10mer ssRNAmonomer44-180
Assess
SARS-CoV-2 Nucleocapsid N-terminal domain (N-NTD) proteinmonomer40-174
Assess
Crystal structure of 2019-nCoV nucleocapsid N-terminal domain (NTD) proteinmonomer47-174
Assess
Crystal structure of the N-terminal domain of SARS-CoV-2 nucleocapsid proteinmonomer47-174
Assess
Structure of SARS-CoV-2 Nucleocapsid Protein N-Terminal Domainmonomer48-174
Assess
Crystal structure of SARS-CoV2 N-NTDmonomer48-174
Assess
Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domainmonomer48-173
Assess
Crystal structure of SARS-CoV-2 N-NTD and dsRNA complexmonomer48-171
EDO;
Assess
Crystal structure of SARS-Cov-2 nucleocapsid N-terminal domain (NTD) protein,pH8.0monomer49-171
Assess

3 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
2ofz.1.Amonomer0.7448-173
92.06
Assess
4ud1.1.Amonomer0.6840-174
55.41
Assess
6wzq.2.Bmonomer0.60250-364
100.00
Assess